Evidence map›Paper›PMID 31430366›Full record

ArticleThe Journal of antimicrobial chemotherapy2019

Intervention planning for Antibiotic Review Kit (ARK): a digital and behavioural intervention to safely review and reduce antibiotic prescriptions in acute and general medicine.

M Santillo, K Sivyer, A Krusche, F Mowbray, N Jones, T E A Peto, A S Walker, M J Llewelyn, L Yardley, ARK-Hospital

Open access · hybridAbstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 4 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 4 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Tailored interventions to address determinants of practice.The Cochrane database of systematic reviews · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Supporting families managing childhood eczema: developing and optimising eczema care online using qualitative research.The British journal of general practice : the journal of the Royal College of General Practitioners · 2022
    Pooled it
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

M SantilloCentre for Clinical and Community Applications of Health Psychology, University of Southampton, Southampton, UK.
K SivyerCentre for Clinical and Community Applications of Health Psychology, University of Southampton, Southampton, UK.
A KruscheCentre for Clinical and Community Applications of Health Psychology, University of Southampton, Southampton, UK.
F MowbrayCentre for Clinical and Community Applications of Health Psychology, University of Southampton, Southampton, UK.
N JonesOxford University Hospitals NHS Foundation Trust, Oxford, UK.
T E A PetoOxford University Hospitals NHS Foundation Trust, Oxford, UK.
A S WalkerNuffield Department of Medicine, University of Oxford, Oxford, UK.
M J LlewelynBrighton and Sussex Medical School, University of Sussex, Falmer, UK.
L YardleyCentre for Clinical and Community Applications of Health Psychology, University of Southampton, Southampton, UK.
ARK-Hospital
University of Southampton · GBOxford University Hospitals NHS Trust · GBUniversity of Oxford · GBBrighton and Sussex Medical School · GBUniversity of Bristol · GB

Funding

Department of Health RP-PG-0514-20015
6 · The paper itself

Abstract

backgroundHospital antimicrobial stewardship strategies, such as 'Start Smart, Then Focus' in the UK, balance the need for prompt, effective antibiotic treatment with the need to limit antibiotic overuse using 'review and revise'. However, only a minority of review decisions are to stop antibiotics. Research suggests that this is due to both behavioural and organizational factors.

objectivesTo develop and optimize the Antibiotic Review Kit (ARK) intervention. ARK is a complex digital, organizational and behavioural intervention that supports implementation of 'review and revise' to help healthcare professionals safely stop unnecessary antibiotics.

methodsA theory-, evidence- and person-based approach was used to develop and optimize ARK and its implementation. This was done through iterative stakeholder consultation and in-depth qualitative research with doctors, nurses and pharmacists in UK hospitals. Barriers to and facilitators of the intervention and its implementation, and ways to address them, were identified and then used to inform the intervention's development.

resultsA key barrier to stopping antibiotics was reportedly a lack of information about the original prescriber's rationale for and their degree of certainty about the need for antibiotics. An integral component of ARK was the development and optimization of a Decision Aid and its implementation to increase transparency around initial prescribing decisions.

conclusionsThe key output of this research is a digital and behavioural intervention targeting important barriers to stopping antibiotics at review (see http://bsac-vle.com/ark-the-antibiotic-review-kit/ and http://antibioticreviewkit.org.uk/). ARK will be evaluated in a feasibility study and, if successful, a stepped-wedge cluster-randomized controlled trial at acute hospitals across the NHS.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipDrug PrescriptionsGeneral PracticeHealth PersonnelHealth Plan ImplementationHospitalsHumansQualitative ResearchStakeholder ParticipationUnited KingdomAnti-Bacterial Agents

Identifiers

PMID31430366
PMCPMC6798845
OpenAlexW2963675456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.